-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-15
Use dual fluorescence to separate mRNA uptake from productive EGFP expression in nanoparticle validation, macrophage studies, and quantitative transfection screens. This workflow combines Cy5 trafficking data, functional translation readouts, and reference-informed formulation controls for faster troubleshooting.
-
miR-24-3p, Sp1/PI3K, and Doxorubicin Heart Failure
2026-09-15
The reference study identifies miR-24-3p as a detrimental regulator of doxorubicin-induced cardiac injury and places Sp1/PI3K signaling downstream of this microRNA. By combining rat and H9c2 models with molecular, functional, and reporter assays, the work provides a mechanistic framework for studying apoptosis and oxidative stress in heart failure models.
-
Making mRNA Delivery Visible: From Uptake to Translation
2026-09-14
Translational mRNA research needs more than a fluorescent signal or a protein endpoint. This thought-leadership guide explains how ARCA Cy5 EGFP mRNA (5-moUTP) can connect particle uptake, intracellular localization, and functional translation while helping researchers evaluate delivery platforms with greater mechanistic precision.
-
G007-LK: Decode Wnt–Hippo Crosstalk
2026-09-14
G007-LK is a selective tankyrase 1/2 inhibitor for dissecting how Wnt/β-catenin and Hippo signaling converge in cancer models. This article presents an assay-centered framework for connecting target engagement, β-catenin degradation, YAP regulation, and translational interpretation.
-
Cy5-UTP Workflow for RNA Tracking and FISH
2026-09-13
Cy5-UTP enables direct, far-red visualization of T7-transcribed RNA for FISH, multicolor imaging, and expression analysis without a secondary staining step. This practical guide connects probe synthesis and assay optimization with new evidence that cholesterol-rich lipid nanoparticles can become trapped in peripheral early endosomes.
-
PPP1R3G–PP1γ Control of RIPK1 Cell Death
2026-09-12
The reference study identifies PPP1R3G as a critical adaptor that recruits PP1γ to dephosphorylate RIPK1 and enable RIPK1-dependent apoptosis and type I necroptosis. Its combination of sensitized CRISPR screening, biochemical rescue experiments, phosphosite manipulation, and mouse genetics provides a mechanistic framework for understanding how inhibitory RIPK1 phosphorylation is removed during inflammatory cell death.
-
Wnt/NR2F2 Drives Platinum Resistance in Brain Metastasis
2026-09-12
This study connects acquired platinum resistance in lung cancer-derived brain metastases to high glutathione consumption, GPX4/GSTM1 activity, and suppression of ferroptosis. Its mechanistic model places Wnt/NR2F2-dependent transcription upstream of GPX4, suggesting that combining platinum treatment with GPX4-directed intervention may be a rational preclinical strategy.
-
SEMA3E, β-Catenin, and Beige Fat Thermogenesis
2026-09-11
A 2026 mouse study identifies the secreted semaphorin SEMA3E as a positive regulator of beige adipocyte differentiation and non-shivering thermogenesis. By combining genetic perturbation, adipose transplantation, mitochondrial respiration measurements, RNA sequencing, and pathway rescue, the work connects SEMA3E activity with oxidative phosphorylation and Wnt/β-catenin signaling.
-
Monomethyl auristatin E: Workflow for ADC Studies
2026-09-11
Monomethyl auristatin E (MMAE) provides a potent free-payload benchmark for ADC cytotoxicity, microtubule-disruption assays, and state-dependent cancer models. This practical guide connects MMAE dosing and troubleshooting with the EBV-driven plasticity findings reported in nasopharyngeal carcinoma, while clearly separating established evidence from proposed assay extensions.
-
PYR-41, inhibitor of Ubiquitin-Activating Enzyme (E1)
2026-09-10
A scenario-driven guide to using PYR-41, inhibitor of Ubiquitin-Activating Enzyme (E1) (SKU B1492) in viability, proliferation, cytotoxicity, ubiquitination, and NF-κB studies. It connects product-specific solubility and efficacy data with practical controls, interpretation strategies, and vendor-selection criteria.
-
Cy5.5 NHS Ester for Biomolecule Imaging
2026-09-10
Cy5.5 NHS ester combines amine-reactive conjugation with near-infrared detection for protein, peptide, oligonucleotide, and nanoparticle workflows. This guide translates its chemistry into reproducible labeling, in vivo fluorescence imaging, and assay-design decisions inspired by a brain-targeted sononeuromodulation platform.
-
PS Nanoplastics–Cadmium Apoptosis via IP3R/Ca2+
2026-09-09
The reference study shows that combined exposure to polystyrene nanoplastics and cadmium promotes intestinal apoptosis in both C. elegans and Caco-2 cells. Its key mechanistic contribution is the identification of an IP3R/Ca2+/STAT3 signaling axis, supported by inhibitor and calcium-chelation experiments. These findings provide a useful framework for interpreting calcium signaling modulation in environmental toxicology and apoptosis research.
-
Etomoxir for Fatty Acid Oxidation Research
2026-09-09
Use Etomoxir to connect CPT-1-dependent fatty acid oxidation with cytokine responses in standardized whole-blood assays. This workflow emphasizes dose-aware controls, donor reproducibility, and careful separation of CPT-1 effects from higher-dose DGAT activity.
-
Pheromone-Driven Neurodegeneration in C. elegans
2026-09-08
Peng et al. show that pheromone exposure during the L1 developmental stage can reconfigure neural signaling in Caenorhabditis elegans and increase neurodegeneration later in life. Their work identifies a coordinated ASK–ASI–AIA circuit that links early chemical perception to insulin-like signaling and reduced neuronal autophagy, offering a mechanistic framework for studying environmental regulation of proteostasis.
-
Poly (I:C) Workflows for Innate Immune Assays
2026-09-08
Poly (I:C) gives researchers a controllable dsRNA trigger for interferon induction, dendritic-cell activation, antiviral modeling, and immune-stress studies in hPSC-derived cardiomyocytes. This practical guide pairs water-based handling with response-versus-toxicity controls and applies a liver-disease cell-death framework to sharpen assay interpretation.